Evidence map›Paper›PMID 38911828›Full record

ArticleRSC advances2024

Squaramide-catalyzed enantioselective Michael addition of nitromethane to 2-enoylazaarenes: synthesis of chiral azaarene-containing γ-nitroketones.

Hong-Ping Huang, Yu-Hang Xie, Xu-Mei Gan, Xin-Yu Wen, Cui-Xia Wang, Yan-Qiu Deng, Zhen-Wei Zhang

Abstract read
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hong-Ping HuangCollege of Pharmacy, Guangxi Zhuang Yao Medicine Center of Engineering and Technology, Guangxi University of Chinese Medicine Nanning Guangxi 530200 P. R. of China charliezh@163.com dengyanqiu0501@163.com.
Yu-Hang XieCollege of Pharmacy, Guangxi Zhuang Yao Medicine Center of Engineering and Technology, Guangxi University of Chinese Medicine Nanning Guangxi 530200 P. R. of China charliezh@163.com dengyanqiu0501@163.com.
Xu-Mei GanCollege of Pharmacy, Guangxi Zhuang Yao Medicine Center of Engineering and Technology, Guangxi University of Chinese Medicine Nanning Guangxi 530200 P. R. of China charliezh@163.com dengyanqiu0501@163.com.
Xin-Yu WenCollege of Pharmacy, Guangxi Zhuang Yao Medicine Center of Engineering and Technology, Guangxi University of Chinese Medicine Nanning Guangxi 530200 P. R. of China charliezh@163.com dengyanqiu0501@163.com.
Cui-Xia WangCollege of Pharmacy, Guangxi Zhuang Yao Medicine Center of Engineering and Technology, Guangxi University of Chinese Medicine Nanning Guangxi 530200 P. R. of China charliezh@163.com dengyanqiu0501@163.com.
Yan-Qiu DengCollege of Pharmacy, Guangxi Zhuang Yao Medicine Center of Engineering and Technology, Guangxi University of Chinese Medicine Nanning Guangxi 530200 P. R. of China charliezh@163.com dengyanqiu0501@163.com.
Zhen-Wei ZhangCollege of Pharmacy, Guangxi Zhuang Yao Medicine Center of Engineering and Technology, Guangxi University of Chinese Medicine Nanning Guangxi 530200 P. R. of China charliezh@163.com dengyanqiu0501@163.com.ORCID https://orcid.org/0000-0003-1521-5728

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bifunctional chiral squaramide-catalyzed highly enantioselective Michael addition of nitromethane to diverse 2-enoylazaarenes was successfully performed. This protocol provided a set of chiral azaarene-containing γ-nitroketones with up to 98% yield and 98% ee in a solvent-free catalytic system under mild conditions. Furthermore, gram-scale synthetic utility was also showcased.

Identifiers

PMID38911828
PMCPMC11192089

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.